[摘要] 投资要点： 预计大部分重点兲注公司的2014年年报符合预期。平安医药重点兲注的24家医药上市公司中，增长超过100%有福瑞股仹(1730%)、南京医药(300%)、信邦制药(250%)，增速50%-100%的有恒康医疗(50%)，增速30%-50%的有千红制药(32%)...
: expect most emphasis is the company's 2014 annual report in accordance with the expected injection. The key is safe medicine injection of 24 pharmaceutical listing Corporation, grew by more than 100% a Furui Corporation (1730%), Nanjing medicine (300%), Xinbang Pharmaceutical (250%), 50%-100% growth has Hengkang medical (50%), 30%-50% growth has colorful Pharmaceutical (32%)...
